Beaumont’s vision to provide compassionate, extraordinary care every day is advanced by its commitment to a robust research program, led by the Beaumont Research Institute (BRI). For more than 50 years, our translational research, which currently ranges from laboratory and pre-clinical investigation to clinical, nursing, quality/safety, population health informatics and learning health system initiatives, has focused on improving health care delivery, patient outcomes and the health of our local and global communities.
As an academic health system, Beaumont is committed to advancing its impact on health through scholarship and training of future generations of health care professionals. Our excellence in patient care provides the foundation for research and innovation that focuses on patients and populations to advance diagnosis, treatment and prevention of disease. Our investigators, many of whom are faculty at Oakland University William Beaumont School of Medicine, work collaboratively to focus on research that accelerates new knowledge, transitioning it out of the laboratory to the patient's bedside and ultimately to the community.
Research at BRI is supported by a strong institutional commitment and extramural funding from numerous sources including: federal, state and non-governmental agencies; industry; generous donors; and revenue from commercialization. These funds support balanced approach of pre-clinical and clinical investigation. Our clinical research is driven by more than 400 active investigators, offering more than 1,200 clinical studies, including more than 350 interventional studies, and enrolling more than 5,000 research participants annually.